A phase 3 CheckMate-498 study comparing radiotherapy with temozolomide and radiotherapy with nivolumab did not meet the primary endpoint of overall survival in patients with newly diagnosed MGMT-unmethylated glioblastoma patients [14]. Here, MGMT is linked to glioblastoma.